General
Preferred name
isoprenaline
Synonyms
ISOPROTERENOL HYDROCHLORIDE ()
(±)-Isoproterenol hydrochloride ()
Medihaler-Iso ()
Isopropylarterenol Sulfate ()
Norisodrine ()
ISOPROTERENOL ()
Isoproterenol (-) ()
Isoproterenol,(+) ()
NCI-c55630 ()
Isoprenaline HCl ()
Isoproterenol sulfate dihydrate ()
ISOPROTERENOL SULFATE ANHYDROUS ()
Isoproterenol HCl ()
ISOPROTERENOL HYDROCHLORIDE51-30-9 ()
Isoprenaline (hydrochloride) ()
Isoproterenol (hydrochloride) ()
NCI-c55630,Isoproterenol hydrochloride ()
Isoprenaline (NCI-C55630) HCl ()
Isoprenaline hydrochloride ()
ISOPROTERENOL SULFATE ()
Norisodrine Aerotrol ()
Dl-isoprenaline hydrochloride ()
Isovon ()
Isoproterenol hydrochloride component of duo-medihaler ()
NSC-89747 ()
Aerotrol ()
Mistarel ()
Vapo-Iso ()
NSC-37745 ()
Oriconazole ()
Euspiran ()
Isoprenaline hydrochloride, dl- ()
Isoproterenol HCl ()
Isomenyl ()
Suscardia ()
Isuprel ()
Isoproterenol dl-form hydrochloride ()
Aerolone ()
Imuprel ()
Asmalar ()
Aludrine ()
Proternol ()
NSC-33791 ()
Isoprenaline ()
NSC-9975 ()
Asiprenol ()
Vapo-n-iso ()
Neodrenal ()
Novodrin ()
Isopropydrin ()
Saventrine ()
A-21 ()
Isonorin ()
Isorenin ()
Isoproterenol dl-form ()
Isoprenalina ()
Isupren ()
Neo-epinine ()
Assiprenol ()
Aleudrin ()
Bellasthman ()
Respifral ()
Isoproterenol dl-form sulfate dihydrate ()
Propal ()
Isoprenalini sulfas ()
Isoprenaline sulfate ()
Isomist ()
Isoprenaline sulfate dihydrate ()
Isoproterenol sulphate ()
Isoprenaline sulphate ()
Aludrin ()
Isoproterenol-d7 (hydrochloride) ()
P&D ID
PD009570
CAS
51-30-9
6779-80-2
114-45-4
1336-89-6
7683-59-2
2964-04-7
149-53-1
6700-39-6
299-95-6
2517584-04-0
Tags
available
drug
biased GPCR ligand
Approved by
FDA
First approval
1956
Drug indication
Congestive heart failure
Melanoma
Atrial fibrillation
Heart block
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Isoprenaline (Isoproterenol) hydrochloride is a non-selective, orally active ¦Â-adrenergic receptor agonist. Isoprenaline has potent peripheral vasodilator, bronchodilator, and cardiac stimulating activities. Isoprenaline can be used for the research of bradycardia and bronchial asthma[1][2][3][4][5][6].
PRICE
29
DESCRIPTION
Isoprenaline is a β-adrenoceptor agonist drug.
(GtoPdb)
PRICE
735
DESCRIPTION
Isoprenaline(Norisodrine) is a non-selective and orally active ??-adrenoceptor agonist.Isoproterenol is a potent peripheral vasodilator and bronchodilator.Isoproterenol can be used in the study of bradycardia and bronchial asthma for the treatment of heart block, bradycardia.
DESCRIPTION
Hypolipidemic agent; agonist for the GPR109A (HM74A) and GPR109B receptors
(Tocris Bioactive Compound Library)
DESCRIPTION
Sympathomimetic amine acting almost exclusively on beta adrenoceptors; bronchodilator
(LOPAC library)
DESCRIPTION
Standard selective β agonist
(Tocriscreen Total)
DESCRIPTION
Isoprenaline is a non-selective beta adrenergic receptor agonist. It is indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock.
(Enamine Bioactive Compounds)
DESCRIPTION
Isoprenaline hydrochloride (NCI-c55630) is a potent beta-adrenergic agonist with the peripheral vasodilator, bronchodilator, and cardiac stimulating properties.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Isoproterenol can be used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma. It is a non-selective β adrenoreceptor agonist and TAAR1 agonist that is structurally similar to epinephrine.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
2
Organisms
4
Compound Sets
38
BiasDB
BOC Sciences Bioactive Compounds
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
105
Molecular Weight
211.12
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
4
Ring Count
1
Aromatic Ring Count
1
cLogP
1.13
TPSA
72.72
Fraction CSP3
0.45
Chiral centers
1.0
Largest ring
6.0
QED
0.56
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
beta
MOA
Adrenergic Receptor agonist
PDE
Agonist
beta-Adrenoceptor Agonists
Target
Adrenergic receptor beta
Adrenergic Receptor
CAMP PDE
Endogenous Metabolite
PI3K
Primary Target
Non-selective Adrenergic ? Receptors
Member status
member
Pathway
GPCR/G protein
Metabolism
Neuroscience
PI3K/Akt/mTOR signaling
Metabolic Enzyme/Protease
Neuronal Signaling
Therapeutic Class
Cardiotonic Agents
Solubility
Soluble in DMSO
Source data

